| PERIOD ENDING | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | 27-Sep-08 | | Total Revenue | 3,229,000 | 3,169,000 | 2,933,000 | 3,288,000 | | Cost of Revenue | 1,825,000 | 1,867,000 | 1,777,000 | 1,885,000 | | | Gross Profit | 1,404,000 | 1,302,000 | 1,156,000 | 1,403,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 851,000 | 773,000 | 811,000 | 870,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 553,000 | 529,000 | 345,000 | 533,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 9,000 |
-
| (6,000) | 13,000 | | Earnings Before Interest And Taxes | 562,000 | 529,000 | 339,000 | 546,000 | | Interest Expense | 67,000 | 67,000 | 78,000 | 71,000 | | Income Before Tax | 495,000 | 462,000 | 261,000 | 475,000 | | Income Tax Expense | 141,000 | 143,000 | 82,000 | 133,000 | | Minority Interest | 3,000 |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 356,000 | 319,000 | 179,000 | 342,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 356,000 | 319,000 | 179,000 | 342,000 | | Preferred Stock And Other Adjustments | (2,000) | 2,000 |
-
|
-
| | | Net Income Applicable To Common Shares | $354,000 | $321,000 | $179,000 | $342,000 |
|
0.17% Nasdaq 0.00%
Income Statement
